MSD set to take on Pfizer in Oz after Samsung Bioepis' biosimilar Enbrel is approved
Australian regulators have approved Samsung Bioepis’ Enbrel (etanercept) biosimilar in both auto-injector and prefilled syringe formats.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs